Ligand Pharmaceuticals
LGND
#3055
Rank
A$7.49 B
Marketcap
A$374.08
Share price
3.09%
Change (1 day)
116.30%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$0.76 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are A$0.76 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$0.81 B353.27%
2024-12-31A$0.17 B41.3%
2023-12-31A$0.12 B-47.81%
2022-12-31A$0.24 B-63.06%
2021-12-31A$0.65 B-22.59%
2020-12-31A$0.84 B-18.32%
2019-12-31A$1.03 B4.61%
2018-12-31A$0.99 B207.33%
2017-12-31A$0.32 B0.99%
2016-12-31A$0.32 B3.11%
2015-12-31A$0.31 B8.75%
2014-12-31A$0.28 B362.12%
2013-12-31A$61.77 M-17.46%
2012-12-31A$74.84 M-31.73%
2011-12-31A$0.10 B38.48%
2010-12-31A$79.15 M-48.49%
2009-12-31A$0.15 B-40.36%
2008-12-31A$0.25 B56.28%
2007-12-31A$0.16 B-56.48%
2006-12-31A$0.37 B-34.77%
2005-12-31A$0.58 B10.24%
2004-12-31A$0.52 B11.4%
2003-12-31A$0.47 B32.32%
2002-12-31A$0.35 B4.05%
2001-12-31A$0.34 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$170.17 B 22,284.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$166.63 B 21,818.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$121.37 B 15,864.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$118.43 B 15,479.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A$19.66 B 2,486.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$117.64 B 15,374.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$94.35 B 12,311.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$85.56 B 11,154.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
A$0.11 B-84.88%๐Ÿ‡บ๐Ÿ‡ธ USA